Dispelling confusion about de-prescribing bisphosphonates

Med J Aust. 2019 Jan;210(1):17-19. doi: 10.5694/mja2.12058. Epub 2018 Dec 20.

Authors

John A Eisman^{1

2}, Christopher P White³

Affiliations

¹ Garvan Institute of Medical Research, St Vincent's Hospital, Sydney, NSW.
² University of Notre Dame Australia, Sydney, NSW.
³ Prince of Wales Hospital, Sydney, NSW.

PMID: 30636304
DOI: 10.5694/mja2.12058

No abstract available

Keywords: Fractures, bone; Osteoporosis.

Publication types

Editorial

MeSH terms

Adult
Aged
Bone Density Conservation Agents* / administration & dosage
Bone Density Conservation Agents* / adverse effects
Bone Density Conservation Agents* / therapeutic use
Deprescriptions*
Diphosphonates* / administration & dosage
Diphosphonates* / adverse effects
Diphosphonates* / therapeutic use
Female
Fractures, Bone / chemically induced
Humans
Middle Aged
Osteoporosis / drug therapy
Risk Assessment

Substances

Bone Density Conservation Agents
Diphosphonates